Vikram Sinha

3.3k total citations
76 papers, 2.4k citations indexed

About

Vikram Sinha is a scholar working on Surgery, Statistics and Probability and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Vikram Sinha has authored 76 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 17 papers in Statistics and Probability and 16 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Vikram Sinha's work include Statistical Methods in Clinical Trials (17 papers), Diabetes Management and Research (15 papers) and Pharmaceutical studies and practices (15 papers). Vikram Sinha is often cited by papers focused on Statistical Methods in Clinical Trials (17 papers), Diabetes Management and Research (15 papers) and Pharmaceutical studies and practices (15 papers). Vikram Sinha collaborates with scholars based in United States, United Kingdom and Singapore. Vikram Sinha's co-authors include Ping Zhao, Vicky Hsu, Christian Wagner, Joseph A. Grillo, Dinesh P. de Alwis, S-M Huang, Scott J. Jacober, Lokesh Jain, Yuzhuo Pan and Daniel C. Howey and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes Care and Cancer Research.

In The Last Decade

Vikram Sinha

72 papers receiving 2.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Vikram Sinha	669	469	460	459	422	76	2.4k
Jenny Y. Chien	327 0.5×	951 2.0×	479 1.0×	536 1.2×	285 0.7×	48	2.2k
Ulrich Broeckel	293 0.4×	1.1k 2.4×	987 2.1×	295 0.6×	506 1.2×	95	3.9k
Alexander Staab	541 0.8×	445 0.9×	175 0.4×	231 0.5×	138 0.3×	54	2.0k
Ron HN van Schaik	780 1.2×	583 1.2×	1.2k 2.7×	163 0.4×	447 1.1×	92	3.2k
Rashmi R. Shah	608 0.9×	1.4k 2.9×	518 1.1×	117 0.3×	152 0.4×	85	3.4k
Pascal Girard	602 0.9×	366 0.8×	201 0.4×	74 0.2×	170 0.4×	102	2.3k
Jogarao Gobburu	1.2k 1.8×	946 2.0×	399 0.9×	146 0.3×	302 0.7×	163	5.0k
Danièle Ouellet	1.3k 1.9×	1.4k 3.0×	318 0.7×	121 0.3×	171 0.4×	93	3.3k
Paul Martin	799 1.2×	570 1.2×	383 0.8×	182 0.4×	705 1.7×	50	2.2k
Christophe Schmitt	377 0.6×	597 1.3×	341 0.7×	354 0.8×	299 0.7×	73	3.8k

Countries citing papers authored by Vikram Sinha

Since Specialization

Citations

This map shows the geographic impact of Vikram Sinha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikram Sinha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikram Sinha more than expected).

Fields of papers citing papers by Vikram Sinha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikram Sinha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikram Sinha. The network helps show where Vikram Sinha may publish in the future.

Co-authorship network of co-authors of Vikram Sinha

This figure shows the co-authorship network connecting the top 25 collaborators of Vikram Sinha. A scholar is included among the top collaborators of Vikram Sinha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikram Sinha. Vikram Sinha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Galluppi, Gerald R., Malidi Ahamadi, Nageshwar Budha, et al.. (2024). Considerations for Industry—Preparing for the FDA Model‐Informed Drug Development (MIDD) Paired Meeting Program. Clinical Pharmacology & Therapeutics. 116(2). 282–288. 6 indexed citations

Sinha, Vikram, et al.. (2023). Drafting a pro-antitrust and data protection regulatory framework. 4(5 (Sep-Oct)). 35–56. 3 indexed citations

Sinha, Vikram, et al.. (2023). The great cover up: Environmental toll of excessive surgical draping in minimally invasive surgery. Journal of Plastic Reconstructive & Aesthetic Surgery. 82. 209–210. 1 indexed citations

Gupta, Neeraj, Michael J. Hanley, Robert Griffin, et al.. (2023). Clinical Pharmacology of Brigatinib: A Next-Generation Anaplastic Lymphoma Kinase Inhibitor. Clinical Pharmacokinetics. 62(8). 1063–1079. 7 indexed citations

Sinha, Vikram, et al.. (2021). Trapeziectomy versus joint replacement for first carpometacarpal (CMC 1) joint osteoarthritis: a systematic review and meta-analysis. European Journal of Orthopaedic Surgery & Traumatology. 32(6). 1001–1021. 26 indexed citations

Romero, Klaus, Daniela J. Conrado, Jackson Burton, et al.. (2019). Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's Disease. Clinical and Translational Science. 12(3). 240–246. 12 indexed citations

Turner, David C., Anna Kondic, Keaven M. Anderson, et al.. (2018). Pembrolizumab Exposure–Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance. Clinical Cancer Research. 24(23). 5841–5849. 156 indexed citations

Zadezensky, Immo, Jean‐Marc Guettier, Liang Li, et al.. (2018). Use of a Systems Pharmacology Model Based Approach Toward Dose Optimization of Parathyroid Hormone Therapy in Hypoparathyroidism. Clinical Pharmacology & Therapeutics. 105(3). 710–718. 12 indexed citations

Linnebjerg, Helle, et al.. (2016). Pharmacokinetics of the Long‐Acting Basal Insulin LY2605541 in Subjects With Varying Degrees of Renal Function. Clinical Pharmacology in Drug Development. 5(3). 216–224. 6 indexed citations

10.

Wagner, Christian, Yuzhuo Pan, Vicky Hsu, Vikram Sinha, & Ping Zhao. (2015). Predicting the Effect of CYP3A Inducers on the Pharmacokinetics of Substrate Drugs Using Physiologically Based Pharmacokinetic (PBPK) Modeling: An Analysis of PBPK Submissions to the US FDA. Clinical Pharmacokinetics. 55(4). 475–483. 78 indexed citations

11.

Offringa, Martin, Jonathan M. Davis, M. Turner, et al.. (2015). Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates: Report of the US Food and Drug Administration First Annual Neonatal Scientific Workshop, October 28–29, 2014. Therapeutic Innovation & Regulatory Science. 49(5). 623–631. 7 indexed citations

12.

Sinha, Vikram, et al.. (2014). Single‐dose pharmacokinetics and glucodynamics of the novel, long‐acting basal insulin LY2605541 in healthy subjects. The Journal of Clinical Pharmacology. 54(7). 792–799. 34 indexed citations

13.

Wagner, Christian, Yuzhuo Pan, Vicky Hsu, et al.. (2014). Predicting the Effect of Cytochrome P450 Inhibitors on Substrate Drugs: Analysis of Physiologically Based Pharmacokinetic Modeling Submissions to the US Food and Drug Administration. Clinical Pharmacokinetics. 54(1). 117–127. 119 indexed citations

14.

Schneck, Karen, et al.. (2012). Assessment of glycemic response to an oral glucokinase activator in a proof of concept study: application of a semi-mechanistic, integrated glucose-insulin-glucagon model. Journal of Pharmacokinetics and Pharmacodynamics. 40(1). 67–80. 23 indexed citations

15.

Schneck, Karen, et al.. (2012). Dose selection using a semi-mechanistic integrated glucose-insulin-glucagon model: designing phase 2 trials for a novel oral glucokinase activator. Journal of Pharmacokinetics and Pharmacodynamics. 40(1). 53–65. 11 indexed citations

16.

Gueorguieva, Ivelina, Kimberley Jackson, Steven Wrighton, Vikram Sinha, & Jenny Y. Chien. (2010). Desipramine, substrate for CYP2D6 activity: population pharmacokinetic model and design elements of drug–drug interaction trials. British Journal of Clinical Pharmacology. 70(4). 523–536. 11 indexed citations

17.

Chu, Valeria, Heidi J. Einolf, Raymond Evers, et al.. (2009). In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective. Drug Metabolism and Disposition. 37(7). 1339–1354. 108 indexed citations

18.

Carducci, Michael A., Luna Musib, Merrill S. Kies, et al.. (2006). Phase I Dose Escalation and Pharmacokinetic Study of Enzastaurin, an Oral Protein Kinase C Beta Inhibitor, in Patients With Advanced Cancer. Journal of Clinical Oncology. 24(25). 4092–4099. 150 indexed citations

19.

Zhang, Liping, Vikram Sinha, S. Thomas Forgue, et al.. (2006). Model-Based Drug Development: The Road to Quantitative Pharmacology. Journal of Pharmacokinetics and Pharmacodynamics. 33(3). 369–393. 83 indexed citations

20.

Wilens, Timothy E., et al.. (2002). Fluoxetine Pharmacokinetics in Pediatric Patients. Journal of Clinical Psychopharmacology. 22(6). 568–575. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact